| 1 | participating | 3,835 |
| 2 | practicing | 669 |
| 3 | engaging | 657 |
| 4 | exercising | 471 |
| 5 | staying | 196 |
| 6 | practising | 178 |
| 7 | collaborating | 142 |
| 8 | investing | 49 |
| 9 | sponsoring | 40 |
| 10 | detained | 29 |
| 11 | non-participating | 21 |
| 12 | cooperating | 20 |
| 13 | overburdened | 16 |
| 14 | nonparticipating | 11 |
| 15 | plunging | 10 |
| 16 | seroconverting | 10 |
| 17 | gliomatosis | 9 |
| 18 | resettled | 9 |
| 19 | servicing | 8 |
| 20 | small-holder | 8 |
| 21 | overseas-qualified | 7 |
| 22 | underperforming | 7 |
| 23 | outside/local | 6 |
| 24 | 8338 | 5 |
| 25 | ushering | 5 |
| 26 | 12,194 | 4 |
| 27 | 4401 | 4 |
| 28 | bt-treated | 4 |
| 29 | civils | 4 |
| 30 | cold-activated | 4 |
| 31 | emd-treated | 4 |
| 32 | paarl | 4 |
| 33 | 5,900 | 3 |
| 34 | a267g | 3 |
| 35 | districts/counties | 3 |
| 36 | nondiscriminatory | 3 |
| 37 | nonspecialist | 3 |
| 38 | northfield | 3 |
| 39 | ovipositing | 3 |
| 40 | uninterested | 3 |
| 41 | up-scaling | 3 |
| 42 | -capable | 2 |
| 43 | -non-reducing | 2 |
| 44 | 11,742 | 2 |
| 45 | 26.6-fold | 2 |
| 46 | 3,993 | 2 |
| 47 | 4804 | 2 |
| 48 | 5,738 | 2 |
| 49 | 8393 | 2 |
| 50 | 9,940 | 2 |
| 51 | acyl-lpas | 2 |
| 52 | akonolinga | 2 |
| 53 | batagram | 2 |
| 54 | crazes | 2 |
| 55 | en/vns | 2 |
| 56 | fluorescence-immunohistochemistry | 2 |
| 57 | gii.p16_gii.13 | 2 |
| 58 | government-approved | 2 |
| 59 | hypotension/shock | 2 |
| 60 | i-1c | 2 |
| 61 | longline | 2 |
| 62 | lycopene-treated | 2 |
| 63 | newly-created | 2 |
| 64 | non-board-certified | 2 |
| 65 | non-clia-certified | 2 |
| 66 | not-involved | 2 |
| 67 | partaking | 2 |
| 68 | products/articles | 2 |
| 69 | resettling | 2 |
| 70 | romark | 2 |
| 71 | rs13281615 | 2 |
| 72 | self-enrolled | 2 |
| 73 | teaching-intensive | 2 |
| 74 | trong | 2 |
| 75 | well-experienced | 2 |
| 76 | δ-3 | 2 |
| 77 | ∼5600 | 2 |
| 78 | 'twice | 1 |
| 79 | -0.49±0.11 | 1 |
| 80 | -29.99 | 1 |
| 81 | -participating | 1 |
| 82 | -specialized | 1 |
| 83 | /neurology | 1 |
| 84 | /trauma | 1 |
| 85 | 0.02±0.2 | 1 |
| 86 | 0.04±0.1 | 1 |
| 87 | 0.63-fold | 1 |
| 88 | 0.75°c | 1 |
| 89 | 1,2,3-thiadiazoles | 1 |
| 90 | 1,703,356 | 1 |
| 91 | 1.0/100,000 | 1 |
| 92 | 1.15-fold | 1 |
| 93 | 1.31±0.32m/s | 1 |
| 94 | 1.46-1.98 | 1 |
| 95 | 1.8-9.3 | 1 |
| 96 | 10.000-20.000 | 1 |
| 97 | 11.1±6.9° | 1 |
| 98 | 12.58±9.82 | 1 |
| 99 | 123/392 | 1 |
| 100 | 130,512 | 1 |
| 101 | 1400±100c/ml | 1 |
| 102 | 16,534,268 | 1 |
| 103 | 1600±100cfu | 1 |
| 104 | 16±3min | 1 |
| 105 | 2,3,4-trimethoxybenzoate | 1 |
| 106 | 2.1+/-1 | 1 |
| 107 | 2.5-3.5-fold | 1 |
| 108 | 2.6-3:1 | 1 |
| 109 | 2.79±0.87 | 1 |
| 110 | 227,335 | 1 |
| 111 | 23.2-28.5 | 1 |
| 112 | 24,540 | 1 |
| 113 | 268136 | 1 |
| 114 | 28,112 | 1 |
| 115 | 3-7mm | 1 |
| 116 | 3.3-21.6 | 1 |
| 117 | 3.30±1.83 | 1 |
| 118 | 30076 | 1 |
| 119 | 38±12.3min | 1 |
| 120 | 4.33±1.04 | 1 |
| 121 | 4.67±2.94 | 1 |
| 122 | 44,600 | 1 |
| 123 | 5-tables | 1 |
| 124 | 51,802 | 1 |
| 125 | 55.5/1000 | 1 |
| 126 | 56gpa | 1 |
| 127 | 7.91±1.95-4.23±1.21 | 1 |
| 128 | 8.03±1.97-1.37±0.52 | 1 |
| 129 | 8.6±2.5 | 1 |
| 130 | 8.7m | 1 |
| 131 | 958°c | 1 |
| 132 | abhor | 1 |
| 133 | acquiescing | 1 |
| 134 | al-harbi | 1 |
| 135 | amai | 1 |
| 136 | asessment | 1 |
| 137 | aud1576 | 1 |
| 138 | autoimmunology | 1 |
| 139 | bahman | 1 |
| 140 | barnum | 1 |
| 141 | baseline-particularly | 1 |
| 142 | bibby | 1 |
| 143 | bio-related | 1 |
| 144 | bio-tests | 1 |
| 145 | biogasplants | 1 |
| 146 | blri | 1 |
| 147 | bu3p | 1 |
| 148 | calgary-area | 1 |
| 149 | calne | 1 |
| 150 | carb-tcmpa | 1 |
| 151 | cardioscopy | 1 |
| 152 | charentese | 1 |
| 153 | chemical-induction | 1 |
| 154 | co-enrolling | 1 |
| 155 | co-immunopreciptation | 1 |
| 156 | complex-formation | 1 |
| 157 | crest-certified | 1 |
| 158 | cux1 | 1 |
| 159 | dalmer | 1 |
| 160 | dermatosurgeons | 1 |
| 161 | disapprovals | 1 |
| 162 | educational-medical | 1 |
| 163 | ellsa | 1 |
| 164 | eqa-approved | 1 |
| 165 | estradiol-valerat | 1 |
| 166 | executive-level | 1 |
| 167 | fh-cases | 1 |
| 168 | fla-pcr | 1 |
| 169 | fq-prescribing | 1 |
| 170 | gc/ms/ms | 1 |
| 171 | glucose-uptake | 1 |
| 172 | gluten/gliadins | 1 |
| 173 | gulrajani | 1 |
| 174 | h.hypnale | 1 |
| 175 | headache/neurology | 1 |
| 176 | hepatic-dnl | 1 |
| 177 | high-prescribing | 1 |
| 178 | his-213 | 1 |
| 179 | hitex | 1 |
| 180 | holidaying | 1 |
| 181 | hvhsp20 | 1 |
| 182 | ich-e9 | 1 |
| 183 | if/fm | 1 |
| 184 | ikejiani | 1 |
| 185 | impax | 1 |
| 186 | inner-bony | 1 |
| 187 | involving12 | 1 |
| 188 | iress | 1 |
| 189 | jamardihi | 1 |
| 190 | knocking-out | 1 |
| 191 | korean-australians | 1 |
| 192 | l'esperance | 1 |
| 193 | l02-shrna-hsf1 | 1 |
| 194 | light-element | 1 |
| 195 | lmw-heparin | 1 |
| 196 | log-increase | 1 |
| 197 | m3/min/table | 1 |
| 198 | maximum-acyclic-agreement | 1 |
| 199 | melanomacrophage | 1 |
| 200 | mid-altitude | 1 |
| 201 | min-ischemia | 1 |
| 202 | misoprostol-both | 1 |
| 203 | monobenzone | 1 |
| 204 | mouchet | 1 |
| 205 | myricetrin | 1 |
| 206 | n-c₂₄ | 1 |
| 207 | nephrureterectomy | 1 |
| 208 | noelle-neumann | 1 |
| 209 | non-chimpanzee | 1 |
| 210 | nonalexithymics | 1 |
| 211 | nonmerohedry | 1 |
| 212 | nonnephrologist | 1 |
| 213 | northview | 1 |
| 214 | o-vacancy | 1 |
| 215 | oceac-ird | 1 |
| 216 | oct-experienced | 1 |
| 217 | oct3/oct3 | 1 |
| 218 | olivari | 1 |
| 219 | organizations/community | 1 |
| 220 | overchoice | 1 |
| 221 | paladin | 1 |
| 222 | palmitoyl-carnitine | 1 |
| 223 | parents/guardians/patients | 1 |
| 224 | patients-1,182 | 1 |
| 225 | peptide-recognition | 1 |
| 226 | placentomes/endometrium | 1 |
| 227 | primary-health-care | 1 |
| 228 | prodepressant | 1 |
| 229 | progressors/non-progressors | 1 |
| 230 | pulse-electroforming | 1 |
| 231 | quaternary-tertiary | 1 |
| 232 | qus+dxa | 1 |
| 233 | reductions/changes | 1 |
| 234 | replanting | 1 |
| 235 | rhino-surgeons | 1 |
| 236 | ripstein | 1 |
| 237 | s-aureus | 1 |
| 238 | saf-nepal | 1 |
| 239 | schroder | 1 |
| 240 | seattle-tacoma-area | 1 |
| 241 | semans | 1 |
| 242 | senior/community | 1 |
| 243 | sicul1 | 1 |
| 244 | social-health-care | 1 |
| 245 | solleder | 1 |
| 246 | starkey | 1 |
| 247 | stormflows | 1 |
| 248 | sundets | 1 |
| 249 | surgeons/7 | 1 |
| 250 | tartter | 1 |
| 251 | thoracotomy/thoracoscopy | 1 |
| 252 | trauma-accredited | 1 |
| 253 | tree-holes | 1 |
| 254 | tri-o-acetyl-d-galactal | 1 |
| 255 | tribodesorption | 1 |
| 256 | turner-warwick | 1 |
| 257 | under-ascertainment | 1 |
| 258 | uv/esi-ms | 1 |
| 259 | vur-if | 1 |
| 260 | warny | 1 |
| 261 | weeks.many | 1 |
| 262 | win-55,212 | 1 |
| 263 | xylosidases | 1 |
| 264 | yal-irrigation | 1 |
| 265 | yater | 1 |
| 266 | zametkin | 1 |
| 267 | ~25-50-fold | 1 |
| 268 | €26.69/day/person | 1 |
| 1 | 'twice | 1 |
| 2 | -0.49±0.11 | 1 |
| 3 | -29.99 | 1 |
| 4 | -capable | 2 |
| 5 | -non-reducing | 2 |
| 6 | -participating | 1 |
| 7 | -specialized | 1 |
| 8 | /neurology | 1 |
| 9 | /trauma | 1 |
| 10 | 0.02±0.2 | 1 |
| 11 | 0.04±0.1 | 1 |
| 12 | 0.63-fold | 1 |
| 13 | 0.75°c | 1 |
| 14 | 1,2,3-thiadiazoles | 1 |
| 15 | 1,703,356 | 1 |
| 16 | 1.0/100,000 | 1 |
| 17 | 1.15-fold | 1 |
| 18 | 1.31±0.32m/s | 1 |
| 19 | 1.46-1.98 | 1 |
| 20 | 1.8-9.3 | 1 |
| 21 | 10.000-20.000 | 1 |
| 22 | 11,742 | 2 |
| 23 | 11.1±6.9° | 1 |
| 24 | 12,194 | 4 |
| 25 | 12.58±9.82 | 1 |
| 26 | 123/392 | 1 |
| 27 | 130,512 | 1 |
| 28 | 1400±100c/ml | 1 |
| 29 | 16,534,268 | 1 |
| 30 | 1600±100cfu | 1 |
| 31 | 16±3min | 1 |
| 32 | 2,3,4-trimethoxybenzoate | 1 |
| 33 | 2.1+/-1 | 1 |
| 34 | 2.5-3.5-fold | 1 |
| 35 | 2.6-3:1 | 1 |
| 36 | 2.79±0.87 | 1 |
| 37 | 227,335 | 1 |
| 38 | 23.2-28.5 | 1 |
| 39 | 24,540 | 1 |
| 40 | 26.6-fold | 2 |
| 41 | 268136 | 1 |
| 42 | 28,112 | 1 |
| 43 | 3,993 | 2 |
| 44 | 3-7mm | 1 |
| 45 | 3.3-21.6 | 1 |
| 46 | 3.30±1.83 | 1 |
| 47 | 30076 | 1 |
| 48 | 38±12.3min | 1 |
| 49 | 4.33±1.04 | 1 |
| 50 | 4.67±2.94 | 1 |
| 51 | 44,600 | 1 |
| 52 | 4401 | 4 |
| 53 | 4804 | 2 |
| 54 | 5,738 | 2 |
| 55 | 5,900 | 3 |
| 56 | 5-tables | 1 |
| 57 | 51,802 | 1 |
| 58 | 55.5/1000 | 1 |
| 59 | 56gpa | 1 |
| 60 | 7.91±1.95-4.23±1.21 | 1 |
| 61 | 8.03±1.97-1.37±0.52 | 1 |
| 62 | 8.6±2.5 | 1 |
| 63 | 8.7m | 1 |
| 64 | 8338 | 5 |
| 65 | 8393 | 2 |
| 66 | 9,940 | 2 |
| 67 | 958°c | 1 |
| 68 | a267g | 3 |
| 69 | abhor | 1 |
| 70 | acquiescing | 1 |
| 71 | acyl-lpas | 2 |
| 72 | akonolinga | 2 |
| 73 | al-harbi | 1 |
| 74 | amai | 1 |
| 75 | asessment | 1 |
| 76 | aud1576 | 1 |
| 77 | autoimmunology | 1 |
| 78 | bahman | 1 |
| 79 | barnum | 1 |
| 80 | baseline-particularly | 1 |
| 81 | batagram | 2 |
| 82 | bibby | 1 |
| 83 | bio-related | 1 |
| 84 | bio-tests | 1 |
| 85 | biogasplants | 1 |
| 86 | blri | 1 |
| 87 | bt-treated | 4 |
| 88 | bu3p | 1 |
| 89 | calgary-area | 1 |
| 90 | calne | 1 |
| 91 | carb-tcmpa | 1 |
| 92 | cardioscopy | 1 |
| 93 | charentese | 1 |
| 94 | chemical-induction | 1 |
| 95 | civils | 4 |
| 96 | co-enrolling | 1 |
| 97 | co-immunopreciptation | 1 |
| 98 | cold-activated | 4 |
| 99 | collaborating | 142 |
| 100 | complex-formation | 1 |
| 101 | cooperating | 20 |
| 102 | crazes | 2 |
| 103 | crest-certified | 1 |
| 104 | cux1 | 1 |
| 105 | dalmer | 1 |
| 106 | dermatosurgeons | 1 |
| 107 | detained | 29 |
| 108 | disapprovals | 1 |
| 109 | districts/counties | 3 |
| 110 | educational-medical | 1 |
| 111 | ellsa | 1 |
| 112 | emd-treated | 4 |
| 113 | en/vns | 2 |
| 114 | engaging | 657 |
| 115 | eqa-approved | 1 |
| 116 | estradiol-valerat | 1 |
| 117 | executive-level | 1 |
| 118 | exercising | 471 |
| 119 | fh-cases | 1 |
| 120 | fla-pcr | 1 |
| 121 | fluorescence-immunohistochemistry | 2 |
| 122 | fq-prescribing | 1 |
| 123 | gc/ms/ms | 1 |
| 124 | gii.p16_gii.13 | 2 |
| 125 | gliomatosis | 9 |
| 126 | glucose-uptake | 1 |
| 127 | gluten/gliadins | 1 |
| 128 | government-approved | 2 |
| 129 | gulrajani | 1 |
| 130 | h.hypnale | 1 |
| 131 | headache/neurology | 1 |
| 132 | hepatic-dnl | 1 |
| 133 | high-prescribing | 1 |
| 134 | his-213 | 1 |
| 135 | hitex | 1 |
| 136 | holidaying | 1 |
| 137 | hvhsp20 | 1 |
| 138 | hypotension/shock | 2 |
| 139 | i-1c | 2 |
| 140 | ich-e9 | 1 |
| 141 | if/fm | 1 |
| 142 | ikejiani | 1 |
| 143 | impax | 1 |
| 144 | inner-bony | 1 |
| 145 | investing | 49 |
| 146 | involving12 | 1 |
| 147 | iress | 1 |
| 148 | jamardihi | 1 |
| 149 | knocking-out | 1 |
| 150 | korean-australians | 1 |
| 151 | l'esperance | 1 |
| 152 | l02-shrna-hsf1 | 1 |
| 153 | light-element | 1 |
| 154 | lmw-heparin | 1 |
| 155 | log-increase | 1 |
| 156 | longline | 2 |
| 157 | lycopene-treated | 2 |
| 158 | m3/min/table | 1 |
| 159 | maximum-acyclic-agreement | 1 |
| 160 | melanomacrophage | 1 |
| 161 | mid-altitude | 1 |
| 162 | min-ischemia | 1 |
| 163 | misoprostol-both | 1 |
| 164 | monobenzone | 1 |
| 165 | mouchet | 1 |
| 166 | myricetrin | 1 |
| 167 | n-c₂₄ | 1 |
| 168 | nephrureterectomy | 1 |
| 169 | newly-created | 2 |
| 170 | noelle-neumann | 1 |
| 171 | non-board-certified | 2 |
| 172 | non-chimpanzee | 1 |
| 173 | non-clia-certified | 2 |
| 174 | non-participating | 21 |
| 175 | nonalexithymics | 1 |
| 176 | nondiscriminatory | 3 |
| 177 | nonmerohedry | 1 |
| 178 | nonnephrologist | 1 |
| 179 | nonparticipating | 11 |
| 180 | nonspecialist | 3 |
| 181 | northfield | 3 |
| 182 | northview | 1 |
| 183 | not-involved | 2 |
| 184 | o-vacancy | 1 |
| 185 | oceac-ird | 1 |
| 186 | oct-experienced | 1 |
| 187 | oct3/oct3 | 1 |
| 188 | olivari | 1 |
| 189 | organizations/community | 1 |
| 190 | outside/local | 6 |
| 191 | overburdened | 16 |
| 192 | overchoice | 1 |
| 193 | overseas-qualified | 7 |
| 194 | ovipositing | 3 |
| 195 | paarl | 4 |
| 196 | paladin | 1 |
| 197 | palmitoyl-carnitine | 1 |
| 198 | parents/guardians/patients | 1 |
| 199 | partaking | 2 |
| 200 | participating | 3,835 |
| 201 | patients-1,182 | 1 |
| 202 | peptide-recognition | 1 |
| 203 | placentomes/endometrium | 1 |
| 204 | plunging | 10 |
| 205 | practicing | 669 |
| 206 | practising | 178 |
| 207 | primary-health-care | 1 |
| 208 | prodepressant | 1 |
| 209 | products/articles | 2 |
| 210 | progressors/non-progressors | 1 |
| 211 | pulse-electroforming | 1 |
| 212 | quaternary-tertiary | 1 |
| 213 | qus+dxa | 1 |
| 214 | reductions/changes | 1 |
| 215 | replanting | 1 |
| 216 | resettled | 9 |
| 217 | resettling | 2 |
| 218 | rhino-surgeons | 1 |
| 219 | ripstein | 1 |
| 220 | romark | 2 |
| 221 | rs13281615 | 2 |
| 222 | s-aureus | 1 |
| 223 | saf-nepal | 1 |
| 224 | schroder | 1 |
| 225 | seattle-tacoma-area | 1 |
| 226 | self-enrolled | 2 |
| 227 | semans | 1 |
| 228 | senior/community | 1 |
| 229 | seroconverting | 10 |
| 230 | servicing | 8 |
| 231 | sicul1 | 1 |
| 232 | small-holder | 8 |
| 233 | social-health-care | 1 |
| 234 | solleder | 1 |
| 235 | sponsoring | 40 |
| 236 | starkey | 1 |
| 237 | staying | 196 |
| 238 | stormflows | 1 |
| 239 | sundets | 1 |
| 240 | surgeons/7 | 1 |
| 241 | tartter | 1 |
| 242 | teaching-intensive | 2 |
| 243 | thoracotomy/thoracoscopy | 1 |
| 244 | trauma-accredited | 1 |
| 245 | tree-holes | 1 |
| 246 | tri-o-acetyl-d-galactal | 1 |
| 247 | tribodesorption | 1 |
| 248 | trong | 2 |
| 249 | turner-warwick | 1 |
| 250 | under-ascertainment | 1 |
| 251 | underperforming | 7 |
| 252 | uninterested | 3 |
| 253 | up-scaling | 3 |
| 254 | ushering | 5 |
| 255 | uv/esi-ms | 1 |
| 256 | vur-if | 1 |
| 257 | warny | 1 |
| 258 | weeks.many | 1 |
| 259 | well-experienced | 2 |
| 260 | win-55,212 | 1 |
| 261 | xylosidases | 1 |
| 262 | yal-irrigation | 1 |
| 263 | yater | 1 |
| 264 | zametkin | 1 |
| 265 | ~25-50-fold | 1 |
| 266 | δ-3 | 2 |
| 267 | €26.69/day/person | 1 |
| 268 | ∼5600 | 2 |
| 1 | 1.0/100,000 | 1 |
| 2 | 10.000-20.000 | 1 |
| 3 | 55.5/1000 | 1 |
| 4 | 44,600 | 1 |
| 5 | ∼5600 | 2 |
| 6 | 5,900 | 3 |
| 7 | hvhsp20 | 1 |
| 8 | 24,540 | 1 |
| 9 | 9,940 | 2 |
| 10 | 2.1+/-1 | 1 |
| 11 | 0.04±0.1 | 1 |
| 12 | 4401 | 4 |
| 13 | -0.49±0.11 | 1 |
| 14 | 7.91±1.95-4.23±1.21 | 1 |
| 15 | 2.6-3:1 | 1 |
| 16 | l02-shrna-hsf1 | 1 |
| 17 | sicul1 | 1 |
| 18 | cux1 | 1 |
| 19 | 0.02±0.2 | 1 |
| 20 | 51,802 | 1 |
| 21 | 28,112 | 1 |
| 22 | win-55,212 | 1 |
| 23 | 130,512 | 1 |
| 24 | involving12 | 1 |
| 25 | 11,742 | 2 |
| 26 | 8.03±1.97-1.37±0.52 | 1 |
| 27 | 12.58±9.82 | 1 |
| 28 | patients-1,182 | 1 |
| 29 | 123/392 | 1 |
| 30 | δ-3 | 2 |
| 31 | 1.8-9.3 | 1 |
| 32 | gii.p16_gii.13 | 2 |
| 33 | his-213 | 1 |
| 34 | 3.30±1.83 | 1 |
| 35 | 8393 | 2 |
| 36 | 3,993 | 2 |
| 37 | oct3/oct3 | 1 |
| 38 | 4.33±1.04 | 1 |
| 39 | 4804 | 2 |
| 40 | 4.67±2.94 | 1 |
| 41 | 12,194 | 4 |
| 42 | 8.6±2.5 | 1 |
| 43 | 23.2-28.5 | 1 |
| 44 | rs13281615 | 2 |
| 45 | 227,335 | 1 |
| 46 | 3.3-21.6 | 1 |
| 47 | 268136 | 1 |
| 48 | 1,703,356 | 1 |
| 49 | 30076 | 1 |
| 50 | aud1576 | 1 |
| 51 | surgeons/7 | 1 |
| 52 | 2.79±0.87 | 1 |
| 53 | 8338 | 5 |
| 54 | 5,738 | 2 |
| 55 | 16,534,268 | 1 |
| 56 | 1.46-1.98 | 1 |
| 57 | -29.99 | 1 |
| 58 | ich-e9 | 1 |
| 59 | seattle-tacoma-area | 1 |
| 60 | calgary-area | 1 |
| 61 | akonolinga | 2 |
| 62 | min-ischemia | 1 |
| 63 | /trauma | 1 |
| 64 | 56gpa | 1 |
| 65 | carb-tcmpa | 1 |
| 66 | ellsa | 1 |
| 67 | qus+dxa | 1 |
| 68 | i-1c | 2 |
| 69 | 0.75°c | 1 |
| 70 | 958°c | 1 |
| 71 | well-experienced | 2 |
| 72 | oct-experienced | 1 |
| 73 | overseas-qualified | 7 |
| 74 | non-clia-certified | 2 |
| 75 | non-board-certified | 2 |
| 76 | crest-certified | 1 |
| 77 | self-enrolled | 2 |
| 78 | resettled | 9 |
| 79 | overburdened | 16 |
| 80 | detained | 29 |
| 81 | newly-created | 2 |
| 82 | emd-treated | 4 |
| 83 | lycopene-treated | 2 |
| 84 | bt-treated | 4 |
| 85 | bio-related | 1 |
| 86 | cold-activated | 4 |
| 87 | trauma-accredited | 1 |
| 88 | uninterested | 3 |
| 89 | not-involved | 2 |
| 90 | eqa-approved | 1 |
| 91 | government-approved | 2 |
| 92 | -specialized | 1 |
| 93 | northfield | 3 |
| 94 | ~25-50-fold | 1 |
| 95 | 0.63-fold | 1 |
| 96 | 2.5-3.5-fold | 1 |
| 97 | 1.15-fold | 1 |
| 98 | 26.6-fold | 2 |
| 99 | oceac-ird | 1 |
| 100 | overchoice | 1 |
| 101 | 'twice | 1 |
| 102 | l'esperance | 1 |
| 103 | mid-altitude | 1 |
| 104 | non-chimpanzee | 1 |
| 105 | melanomacrophage | 1 |
| 106 | glucose-uptake | 1 |
| 107 | h.hypnale | 1 |
| 108 | -capable | 2 |
| 109 | m3/min/table | 1 |
| 110 | longline | 2 |
| 111 | palmitoyl-carnitine | 1 |
| 112 | calne | 1 |
| 113 | monobenzone | 1 |
| 114 | social-health-care | 1 |
| 115 | primary-health-care | 1 |
| 116 | log-increase | 1 |
| 117 | charentese | 1 |
| 118 | 2,3,4-trimethoxybenzoate | 1 |
| 119 | teaching-intensive | 2 |
| 120 | vur-if | 1 |
| 121 | a267g | 3 |
| 122 | high-prescribing | 1 |
| 123 | fq-prescribing | 1 |
| 124 | practicing | 669 |
| 125 | servicing | 8 |
| 126 | acquiescing | 1 |
| 127 | -non-reducing | 2 |
| 128 | engaging | 657 |
| 129 | plunging | 10 |
| 130 | partaking | 2 |
| 131 | up-scaling | 3 |
| 132 | co-enrolling | 1 |
| 133 | resettling | 2 |
| 134 | pulse-electroforming | 1 |
| 135 | underperforming | 7 |
| 136 | ushering | 5 |
| 137 | sponsoring | 40 |
| 138 | exercising | 471 |
| 139 | practising | 178 |
| 140 | participating | 3,835 |
| 141 | -participating | 1 |
| 142 | non-participating | 21 |
| 143 | nonparticipating | 11 |
| 144 | cooperating | 20 |
| 145 | collaborating | 142 |
| 146 | ovipositing | 3 |
| 147 | replanting | 1 |
| 148 | seroconverting | 10 |
| 149 | investing | 49 |
| 150 | holidaying | 1 |
| 151 | staying | 196 |
| 152 | trong | 2 |
| 153 | misoprostol-both | 1 |
| 154 | amai | 1 |
| 155 | al-harbi | 1 |
| 156 | jamardihi | 1 |
| 157 | ikejiani | 1 |
| 158 | gulrajani | 1 |
| 159 | olivari | 1 |
| 160 | blri | 1 |
| 161 | turner-warwick | 1 |
| 162 | hypotension/shock | 2 |
| 163 | romark | 2 |
| 164 | educational-medical | 1 |
| 165 | outside/local | 6 |
| 166 | saf-nepal | 1 |
| 167 | tri-o-acetyl-d-galactal | 1 |
| 168 | executive-level | 1 |
| 169 | 1400±100c/ml | 1 |
| 170 | hepatic-dnl | 1 |
| 171 | paarl | 4 |
| 172 | 8.7m | 1 |
| 173 | batagram | 2 |
| 174 | if/fm | 1 |
| 175 | 3-7mm | 1 |
| 176 | placentomes/endometrium | 1 |
| 177 | barnum | 1 |
| 178 | bahman | 1 |
| 179 | paladin | 1 |
| 180 | ripstein | 1 |
| 181 | zametkin | 1 |
| 182 | 38±12.3min | 1 |
| 183 | 16±3min | 1 |
| 184 | lmw-heparin | 1 |
| 185 | myricetrin | 1 |
| 186 | noelle-neumann | 1 |
| 187 | yal-irrigation | 1 |
| 188 | complex-formation | 1 |
| 189 | co-immunopreciptation | 1 |
| 190 | chemical-induction | 1 |
| 191 | peptide-recognition | 1 |
| 192 | tribodesorption | 1 |
| 193 | €26.69/day/person | 1 |
| 194 | bu3p | 1 |
| 195 | fla-pcr | 1 |
| 196 | solleder | 1 |
| 197 | small-holder | 8 |
| 198 | schroder | 1 |
| 199 | dalmer | 1 |
| 200 | yater | 1 |
| 201 | tartter | 1 |
| 202 | abhor | 1 |
| 203 | 1.31±0.32m/s | 1 |
| 204 | acyl-lpas | 2 |
| 205 | nonalexithymics | 1 |
| 206 | reductions/changes | 1 |
| 207 | districts/counties | 3 |
| 208 | 5-tables | 1 |
| 209 | products/articles | 2 |
| 210 | tree-holes | 1 |
| 211 | 1,2,3-thiadiazoles | 1 |
| 212 | fh-cases | 1 |
| 213 | xylosidases | 1 |
| 214 | crazes | 2 |
| 215 | gliomatosis | 9 |
| 216 | disapprovals | 1 |
| 217 | civils | 4 |
| 218 | uv/esi-ms | 1 |
| 219 | gc/ms/ms | 1 |
| 220 | korean-australians | 1 |
| 221 | semans | 1 |
| 222 | gluten/gliadins | 1 |
| 223 | rhino-surgeons | 1 |
| 224 | dermatosurgeons | 1 |
| 225 | en/vns | 2 |
| 226 | progressors/non-progressors | 1 |
| 227 | iress | 1 |
| 228 | sundets | 1 |
| 229 | biogasplants | 1 |
| 230 | parents/guardians/patients | 1 |
| 231 | bio-tests | 1 |
| 232 | s-aureus | 1 |
| 233 | stormflows | 1 |
| 234 | estradiol-valerat | 1 |
| 235 | mouchet | 1 |
| 236 | prodepressant | 1 |
| 237 | maximum-acyclic-agreement | 1 |
| 238 | light-element | 1 |
| 239 | under-ascertainment | 1 |
| 240 | asessment | 1 |
| 241 | nonnephrologist | 1 |
| 242 | nonspecialist | 3 |
| 243 | knocking-out | 1 |
| 244 | 1600±100cfu | 1 |
| 245 | northview | 1 |
| 246 | impax | 1 |
| 247 | hitex | 1 |
| 248 | bibby | 1 |
| 249 | o-vacancy | 1 |
| 250 | starkey | 1 |
| 251 | autoimmunology | 1 |
| 252 | /neurology | 1 |
| 253 | headache/neurology | 1 |
| 254 | baseline-particularly | 1 |
| 255 | nephrureterectomy | 1 |
| 256 | weeks.many | 1 |
| 257 | inner-bony | 1 |
| 258 | warny | 1 |
| 259 | thoracotomy/thoracoscopy | 1 |
| 260 | cardioscopy | 1 |
| 261 | quaternary-tertiary | 1 |
| 262 | nonmerohedry | 1 |
| 263 | nondiscriminatory | 3 |
| 264 | fluorescence-immunohistochemistry | 2 |
| 265 | senior/community | 1 |
| 266 | organizations/community | 1 |
| 267 | n-c₂₄ | 1 |
| 268 | 11.1±6.9° | 1 |